Charles Schwab’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.99B | Buy |
54,365,289
+4,600,064
| +9% | +$538M | 0.93% | 16 |
|
|
2026
Q1 | $5.99B | Buy |
49,765,225
+1,201,421
| +2% | +$139M | 0.91% | 15 |
|
|
2025
Q4 | $5.11B | Sell |
48,563,804
-5,135,656
| -10% | -$482M | 0.79% | 22 |
|
|
2025
Q3 | $4.51B | Sell |
53,699,460
-166,006
| -0.3% | -$13.7M | 0.72% | 23 |
|
|
2025
Q2 | $4.26B | Buy |
53,865,466
+4,636,183
| +9% | +$369M | 0.74% | 25 |
|
|
2025
Q1 | $4.42B | Buy |
49,229,283
+29,104,112
| +145% | +$2.72B | 0.83% | 24 |
|
|
2024
Q4 | $2B | Buy |
20,125,171
+1,317,878
| +7% | +$136M | 0.37% | 46 |
|
|
2024
Q3 | $2.14B | Buy |
18,807,293
+514,060
| +3% | +$61.1M | 0.41% | 44 |
|
|
2024
Q2 | $2.26B | Buy |
18,293,233
+643,093
| +4% | +$82.8M | 0.43% | 45 |
|
|
2024
Q1 | $2.29B | Sell |
17,650,140
-19,032,726
| -52% | -$2.35B | 0.53% | 35 |
|
|
2023
Q4 | $3.97B | Buy |
36,682,866
+4,731,152
| +15% | +$491M | 1.01% | 10 |
|
|
2023
Q3 | $3.29B | Buy |
31,951,714
+1,246,705
| +4% | +$134M | 0.94% | 16 |
|
|
2023
Q2 | $3.54B | Buy |
30,705,009
+31,668
| +0.1% | +$3.6M | 1.01% | 13 |
|
|
2023
Q1 | $3.26B | Buy |
30,673,341
+695,692
| +2% | +$75.1M | 0.99% | 15 |
|
|
2022
Q4 | $3.33B | Sell |
29,977,649
-972,799
| -3% | -$99.4M | 1.07% | 10 |
|
|
2022
Q3 | $2.67B | Buy |
30,950,448
+1,429,537
| +5% | +$128M | 0.95% | 13 |
|
|
2022
Q2 | $2.69B | Sell |
29,520,911
-558,751
| -2% | -$49.5M | 0.94% | 13 |
|
|
2022
Q1 | $2.47B | Buy |
30,079,662
+1,077,042
| +4% | +$84.9M | 0.74% | 22 |
|
|
2021
Q4 | $2.22B | Buy |
29,002,620
+1,500,754
| +5% | +$120M | 0.66% | 22 |
|
|
2021
Q3 | $2.07B | Buy |
27,501,866
+1,208,048
| +5% | +$91.9M | 0.68% | 22 |
|
|
2021
Q2 | $2.04B | Buy |
26,293,818
+2,504,844
| +11% | +$186M | 0.68% | 21 |
|
|
2021
Q1 | $1.75B | Buy |
23,788,974
+11,628,109
| +96% | +$858M | 0.64% | 22 |
|
|
2020
Q4 | $949M | Buy |
12,160,865
+64,918
| +0.5% | +$4.96M | 0.38% | 48 |
|
|
2020
Q3 | $957M | Sell |
12,095,947
-465,637
| -4% | -$36.5M | 0.44% | 43 |
|
|
2020
Q2 | $927M | Sell |
12,561,584
-187,321
| -1% | -$14.1M | 0.45% | 41 |
|
|
2020
Q1 | $936M | Buy |
12,748,905
+172,420
| +1% | +$13.6M | 0.55% | 32 |
|
|
2019
Q4 | $1.09B | Buy |
12,576,485
+119,020
| +1% | +$9.78M | 0.59% | 26 |
|
|
2019
Q3 | $1B | Sell |
12,457,465
-201,783
| -2% | -$16.2M | 0.59% | 26 |
|
|
2019
Q2 | $1.01B | Sell |
12,659,248
-153,347
| -1% | -$11.7M | 0.62% | 27 |
|
|
2019
Q1 | $1.02B | Buy |
12,812,595
+524,821
| +4% | +$39.3M | 0.65% | 24 |
|
|
2018
Q4 | $896M | Buy |
12,287,774
+345,924
| +3% | +$24.4M | 0.69% | 23 |
|
|
2018
Q3 | $808M | Buy |
11,941,850
+329,291
| +3% | +$21M | 0.54% | 30 |
|
|
2018
Q2 | $673M | Buy |
11,612,559
+493,451
| +4% | +$27.8M | 0.49% | 32 |
|
|
2018
Q1 | $578M | Buy |
11,119,108
+250,363
| +2% | +$13.5M | 0.45% | 35 |
|
|
2017
Q4 | $584M | Buy |
10,868,745
+279,971
| +3% | +$15.5M | 0.46% | 36 |
|
|
2017
Q3 | $647M | Sell |
10,588,774
-318,987
| -3% | -$19.3M | 0.57% | 30 |
|
|
2017
Q2 | $667M | Sell |
10,907,761
-597,407
| -5% | -$36.4M | 0.63% | 28 |
|
|
2017
Q1 | $698M | Buy |
11,505,168
+22,644
| +0.2% | +$1.37M | 0.7% | 24 |
|
|
2016
Q4 | $645M | Buy |
11,482,524
+297,068
| +3% | +$17.4M | 0.71% | 24 |
|
|
2016
Q3 | $666M | Buy |
11,185,456
+23,643
| +0.2% | +$1.38M | 0.78% | 19 |
|
|
2016
Q2 | $614M | Buy |
11,161,813
+1,188,979
| +12% | +$63.3M | 0.77% | 19 |
|
|
2016
Q1 | $503M | Buy |
9,972,834
+1,462,426
| +17% | +$71.6M | 0.66% | 24 |
|
|
2015
Q4 | $429M | Buy |
8,510,408
+299,042
| +4% | +$15.1M | 0.58% | 29 |
|
|
2015
Q3 | $387M | Sell |
8,211,366
-317,714
| -4% | -$16.9M | 0.57% | 29 |
|
|
2015
Q2 | $464M | Sell |
8,529,080
-1,530,490
| -15% | -$85.8M | 0.64% | 24 |
|
|
2015
Q1 | $552M | Sell |
10,059,570
-99,041
| -1% | -$5.61M | 0.78% | 15 |
|
|
2014
Q4 | $550M | Buy |
10,158,611
+293,757
| +3% | +$16.4M | 0.83% | 16 |
|
|
2014
Q3 | $558M | Buy |
9,864,854
+609,452
| +7% | +$34.2M | 0.92% | 16 |
|
|
2014
Q2 | $511M | Buy |
9,255,402
+1,264,225
| +16% | +$69M | 0.86% | 15 |
|
|
2014
Q1 | $433M | Buy |
7,991,177
+602,202
| +8% | +$31.2M | 0.78% | 16 |
|
|
2013
Q4 | $353M | Sell |
7,388,975
-204,339
| -3% | -$9.34M | 0.67% | 21 |
|
|
2013
Q3 | $353M | Sell |
7,593,314
-1,664,433
| -18% | -$76M | 0.72% | 20 |
|
|
2013
Q2 | $409M | Buy |
+9,257,747
| New | +$413M | 0.91% | 16 |
|
Other funds holding MRK
Charles Schwab's MRK Position: Q2 2026 in Review
Charles Schwab increased its Merck (MRK) stake by 9.2% in Q2 2026, buying an estimated $538M and bringing the position to 54,365,289 shares worth $6.99B. The position accounts for 0.93% of the portfolio, ranked #16.
Charles Schwab first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Charles Schwab held 54,365,289 shares of Merck worth $6.99B as of Q2 2026.
- Charles Schwab bought 4,600,064 Merck shares in Q2 2026, an estimated $538M.
- Merck made up 0.93% of Charles Schwab's portfolio in Q2 2026, its #16 holding.
- Charles Schwab first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.